Research summary ·
Riboflavin therapy in complex I deficiency: Two new cases of leukoencephalopathy and a systematic literature review.
Written based on 1 research study on PubMed, searched on 15 Nov 2026.
What was studied
This paper looks at riboflavin as a treatment for complex I deficiency. Complex I deficiency is a common cause of mitochondrial disease in children. The team looked back at the records of a pair of patients. Both had gene changes that caused the deficiency. They got high doses of riboflavin and were followed for more than 16 years. The team also searched past papers for other cases helped by riboflavin.
What they found
Both patients lost skills quickly at a young age. Their brain scans showed large areas of damaged white matter. Riboflavin, at up to 10 mg/kg/day, was linked to fast recovery. Their brain and nerve function came back almost fully. Lactate levels and nerve signal tests went back to normal. Brain scans got better, and the gains lasted. The search found 43 more cases that responded to riboflavin. These included 16 with heart muscle disease and 12 with muscle disease. There were also 8 with white matter brain disease and 5 with Leigh syndrome.
What it means for patients
The authors say riboflavin may give lasting help in several forms of the disease. Its effect is already shown in heart disease linked to ACAD9 gene changes. They say the evidence supports thinking about trying riboflavin in other forms. Their cases add evidence that riboflavin could help in white matter brain disease. People with changes in NDUFV1, NDUFV2 or NDUFS1 may be good candidates.
Why it is not certain yet
The new part of this paper is based on only a pair of patients. It looked back at past records, with no comparison group. The 8 earlier brain cases had short follow-up and few scans. The authors say new studies that follow people forward are needed. A review can only be as good as the studies in it.
Source
Riboflavin therapy in complex I deficiency: Two new cases of leukoencephalopathy and a systematic literature review.
PubMed · PMID 42476091We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Mitochondrial disease publications